Inovio Pharmaceuticals is trading at $1.34 (-5.63%) amid broad risk-off trading and escalating U.S.-Iran tensions.

  • The S&P 500 is down 0.40%, while the NASDAQ Composite is down 0.61%.
  • Rising Brent crude prices are pressuring equities and investor risk appetite.
  • No new company-specific announcement was identified; a previously announced investor conference is scheduled for 3:20 PM ET on September 9, 2026.